Sensitive detection of wild-type and mutant EGFR by specific ELISA assays in any biological sample

The present invention generally relates a method of detecting type III mutant EGF receptor (EGFRvIII) in biological samples, a method of detecting cancers and other diseases in biological samples, and to a method of assessing treatment and selecting therapy for cancer patients.

Saved in:
Bibliographic Details
Main Authors WONG ALBERT J, LIPTON ALLAN, MOSCATELLO DAVID K, LEITZEL KIM E
Format Patent
LanguageEnglish
Published 29.11.2001
Edition7
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention generally relates a method of detecting type III mutant EGF receptor (EGFRvIII) in biological samples, a method of detecting cancers and other diseases in biological samples, and to a method of assessing treatment and selecting therapy for cancer patients.
Bibliography:Application Number: US20010803854